Literature DB >> 8831126

Streptococcus faecalis disc space infection following transurethral resection of prostate.

A A Faraj1.   

Abstract

The case of a 65-year-old diabetic patient who developed L5/S1 disc space infection caused by Streptococcus faecalis is reported. The patient had a history of a fall followed by transurethral resection of prostate within 2 weeks before presentation. Parenteral vancomycin administered for 6 weeks aborted the infection. The patient made good recovery. This is the first reported case of Streptococcus faecalis primary intervertebral disc space infection. The importance of prophylactic antibiotics during urosurgical operations in diabetic patients is stressed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831126     DOI: 10.1007/bf00395516

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  6 in total

1.  Osteomyelitis of the vertebrae as the result of infection of the urinary tract.

Authors:  S W HENSON; M B COVENTRY
Journal:  Surg Gynecol Obstet       Date:  1956-02

2.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES.

Authors:  O V Batson
Journal:  Ann Surg       Date:  1940-07       Impact factor: 12.969

3.  Septic discitis resulting from Escherichia coli urosepsis.

Authors:  C D Ponte; M McDonald
Journal:  J Fam Pract       Date:  1992-06       Impact factor: 0.493

4.  Urinary tract infections in patients with diabetes mellitus.

Authors:  W C Lye; R K Chan; E J Lee; G Kumarasinghe
Journal:  J Infect       Date:  1992-03       Impact factor: 6.072

5.  Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients.

Authors:  J A Carton; J A Maradona; F J Nuño; R Fernandez-Alvarez; F Pérez-Gonzalez; V Asensi
Journal:  Eur J Med       Date:  1992-09

Review 6.  Enterococcal infections. The increasing threat of nosocomial spread and drug resistance.

Authors:  R K Vemuri; M J Zervos
Journal:  Postgrad Med       Date:  1993-02-15       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.